"The 5-year relative survival rate for all stages of triple negative breast cancer is 77%. This means that women with triple negative breast cancer are, on average, about 77% as likely as women without that cancer to live for at least 5 years after diagnosis. If you are looking to join a triple negative breast cancer clinical trial, Power can help you search recent trials by condition, treatment, or location." - Anonymous Online Contributor
"Triple negative breast cancer can return with a pathologic complete response, but the rates of disease-free survival and overall survival improve with the use of chemotherapy before surgery, which is also known as neoadjuvant chemotherapy. While disease-free survival is how long someone lives without the cancer recurring, overall survival is how long they live whether or not the cancer recurs. You can find the most recent triple negative breast cancer clinical trials by using Power, which allows you to search trials tailored to your condition, location, and ideal treatment." - Anonymous Online Contributor
"While there are currently no clear answers for what causes triple negative breast cancer, current theories suggest that one possible cause is a faulty BRCA1 gene. A BRCA1 mutation leaves the body's cells susceptible to further alterations that can lead to certain types of cancer, including triple negative breast cancer. Power makes it easy to find triple negative breast cancer clinical trials tailored to your condition, treatment, or location." - Anonymous Online Contributor
"Unfortunately, Stage 4 triple negative breast cancer has a dismal prognosis, with the median overall survival being only about 13 months. However, a case report from 2019 describes a 68 year old patient with metastatic TNBC that achieved a long-term, complete remission from the disease. The patient was 7 years out from her diagnosis at the time. While cases like this are possible, more clinical trials are required to improve the survival rate of the disease. To find active triple negative breast cancer clinical trials in your area, you can use Power to search by condition, treatment, or location." - Anonymous Online Contributor
"On ultrasound, triple negative breast cancer frequently presents as an oval or round mass shape. Compared to non-TNBC cancers, it can often look like lesions with benign morphologies. Therefore, it is important that breast lesions are evaluated thoroughly for diagnostic accuracy. If you are looking to join a triple negative breast cancer clinical trial, Power can help you search recent trials by condition, treatment, or location." - Anonymous Online Contributor
"On a mammogram, triple negative breast cancer most commonly appears as an irregular, non-calcified mass with ill-defined or spiculated margins. Most triple negative breast cancers are discovered during a physical exam in younger women without a prior mammogram. You can find the most recent triple negative breast cancer clinical trials by using Power, which allows you to search trials tailored to your condition, location, and ideal treatment." - Anonymous Online Contributor
"Triple negative breast cancer is not a death sentence, as many treatments have allowed patients to thrive after being diagnosed. The disease is also particularly sensitive to chemotherapy, and clinical trials are available when standard treatments are ineffective. Power makes it easy to find triple negative breast cancer clinical trials tailored to your condition, treatment, or location." - Anonymous Online Contributor
"Triple negative breast cancer is an aggressive cancer that grows quickly, making it more likely to have spread by the time it is diagnosed and to come back after treatment. Therefore, the outlook is generally not as good when compared to other types of breast cancer. To find active triple negative breast cancer clinical trials in your area, you can use Power to search by condition, treatment, or location." - Anonymous Online Contributor
"Triple negative breast cancer is a type of breast cancer that lacks the receptors that are commonly found in breast cancer. These receptors are estrogen, progesterone, and human epidermal growth factor (HER2). This means that triple negative breast cancer cannot be treated with hormone therapy like other forms of breast cancer. If you are looking to join a triple negative breast cancer clinical trial, Power can help you search recent trials by condition, treatment, or location." - Anonymous Online Contributor
"A 2014 study found that about 25% of patients with triple negative breast cancer experienced a locoregional or distant recurrence. In the case of distant recurrence, the breast cancer-specific mortality was greater than 75%. You can find the most recent triple negative breast cancer clinical trials by using Power, which allows you to search trials tailored to your condition, location, and ideal treatment." - Anonymous Online Contributor
"A 2017 study found that alcohol induces cell proliferation, migration, and invasion of triple negative breast cancer cells. While alcohol is well-known as a risk factor for breast cancer, the underlying mechanisms of its effects remain unclear. More studies are required to understand alcohol's effect on specific subtypes of breast cancer. Power makes it easy to find triple negative breast cancer clinical trials tailored to your condition, treatment, or location." - Anonymous Online Contributor
"Triple negative breast cancer is an aggressive form of cancer. While some reports suggest that they respond to chemotherapy better than other types of breast cancer, the prognosis for triple negative breast cancer remains poor. To find active triple negative breast cancer clinical trials in your area, you can use Power to search by condition, treatment, or location." - Anonymous Online Contributor
"Triple negative breast cancer tumors can be classified into four distinct subtypes: androgen signaling (LAR), mesenchymal (MES), basal-like immunosuppressed (BLIS), and basal-like immune-activated (BLIA). Among these subtypes, BLIS showed the worst prognosis, while BLIA showed the best. If you are looking to join a triple negative breast cancer clinical trial, Power can help you search recent trials by condition, treatment, or location." - Anonymous Online Contributor
"Symptoms of triple negative breast cancer are similar to other types of breast cancer and include a new lump or thickening in the breast or armpit, a change in size, shape, or feel of the breast, and fluid leaking from the nipple when not pregnant or breastfeeding. It is important to have any symptoms checked by a doctor, who may refer you to a specialist breast clinic. You can find the most recent triple negative breast cancer clinical trials by using Power, which allows you to search trials tailored to your condition, location, and ideal treatment." - Anonymous Online Contributor
"Treatments for triple negative breast cancer such as radiation therapy, chemotherapy, and surgery may make you feel tired during and after treatment. Fatigue can impact work, family, and social activities, and even after treatment ends it might take a while to feel strong again. Power makes it easy to find triple negative breast cancer clinical trials tailored to your condition, treatment, or location." - Anonymous Online Contributor
"About 10 to 30% of women younger than 60 diagnosed with triple negative breast cancer have a BRCA1 or BRCA2 gene mutation. Doctors recommended that patients with triple negative breast cancer receive genetic counseling and testing. However, women under 60 with triple negative breast cancer are at risk of having a BRCA mutation, regardless of their family history. To find active triple negative breast cancer clinical trials in your area, you can use Power to search by condition, treatment, or location." - Anonymous Online Contributor
"Chemotherapy for triple negative breast cancer is usually completed over the course of three to six months. Each treatment session is followed by a period of rest to allow the body time to recover from the side effects. A physician may recommend an additional course of chemotherapy months or years after initial treatment if a patient's cancer recurs. If you are looking to join a triple negative breast cancer clinical trial, Power can help you search recent trials by condition, treatment, or location." - Anonymous Online Contributor
"Immunotherapy through the drug pembrolizumab combined with chemo is often the first treatment for advanced triple negative breast cancer when the cancer cells contain the PD-L1 protein. This is also an option in recurring TNBC that cannot be removed through surgery and makes the PD-L1 protein. You can find the most recent triple negative breast cancer clinical trials by using Power, which allows you to search trials tailored to your condition, location, and ideal treatment." - Anonymous Online Contributor
"There is no absolute way to prevent triple negative breast cancer, but you can reduce your risk by receiving age-appropriate screenings, eating a balanced diet, limiting alcohol intake and getting regular exercise. In addition, knowing your family history of breast cancer can help you take action toward prevention early. Power makes it easy to find triple negative breast cancer clinical trials tailored to your condition, treatment, or location." - Anonymous Online Contributor
"While immunotherapy drugs like atezolizumab and pembrolizumab can be used to treat patients with metastatic triple negative breast cancer, it is not an option for all patients with the disease. This is because these drugs are currently only used when the PD-L1 protein is found in the cancer or immune cells within the tumor. To find active triple negative breast cancer clinical trials in your area, you can use Power to search by condition, treatment, or location." - Anonymous Online Contributor